Functional Deficits in Gut Microbiome of Young and Middle-Aged Adults with Prediabetes Apparent in Metabolizing Bioactive (Poly)phenols

Gut microbiota metabolize select dietary (poly)phenols to absorbable metabolites that exert biological effects important in metabolic health. Microbiota composition associated with health/disease status may affect its functional capacity to yield bioactive metabolites from dietary sources. Therefore...

Full description

Saved in:
Bibliographic Details
Published inNutrients Vol. 12; no. 11; p. 3595
Main Authors Zhang, Xuhuiqun, Zhao, Anqi, Sandhu, Amandeep K, Edirisinghe, Indika, Burton-Freeman, Britt M
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 23.11.2020
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Gut microbiota metabolize select dietary (poly)phenols to absorbable metabolites that exert biological effects important in metabolic health. Microbiota composition associated with health/disease status may affect its functional capacity to yield bioactive metabolites from dietary sources. Therefore, this study assessed gut microbiome composition and its related functional capacity to metabolize fruit (poly)phenols in individuals with prediabetes and insulin resistance (PreDM-IR, = 26) compared to a metabolically healthy Reference group ( = 10). Shotgun sequencing was used to characterize gut microbiome composition. Targeted quantitative metabolomic analyses of plasma and urine collected over 24 h were used to assess microbial-derived metabolites in response to a (poly)phenol-rich raspberry test drink. PreDM-IR compared to the Reference group: (1) enriched and and depleted and . and spp. were depleted in the lean PreDM-IR subset; and (2) impaired microbial catabolism of select (poly)phenols resulting in lower 3,8-dihydroxy-urolithin (urolithin A), phenyl- -valerolactones and various phenolic acids concentrations ( < 0.05). Controlling for obesity revealed relationships with microbial species that may serve as metagenomic markers of diabetes development and therapeutic targets. Data provide insight from multi-omics approaches to advance knowledge at the diet-gut-disease nexus serving as a platform for devising dietary strategies to improve metabolic health.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2072-6643
2072-6643
DOI:10.3390/nu12113595